share_log

Canaccord Genuity Assumes Beauty Health at Buy, Announces Price Target of $10

Canaccord Genuity Assumes Beauty Health at Buy, Announces Price Target of $10

Canaccord Genuity 在买入时假设美容健康,宣布目标价为 10 美元
Benzinga ·  2023/08/25 05:10

Canaccord Genuity analyst Kyle Rose assumes Beauty Health (NASDAQ:SKIN) with a Buy rating and announces Price Target of $10.

Cancord Genuity分析师凯尔·罗斯认为纳斯达克(JD:Skin)的评级为买入,并宣布目标价为10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发